Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory (Q34104222)

31 July 2017

1 reference

title

Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory (English)

1 reference

31 July 2017

1 reference

1 reference

Banatvala J

1

1 reference

31 July 2017

Van Damme P

series ordinal

2

1 reference

31 July 2017

Oehen S

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

31 July 2017

9

1 reference

inferred from page(s)

published in

Vaccine

1 reference

31 July 2017

19

1 reference

31 July 2017

7-8

1 reference

31 July 2017

877-885

1 reference

Status of hepatitis B immunization programmes in 1998

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Universal hepatitis B immunization: infant, and infant plus adolescent immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Are booster immunisations needed for lifelong hepatitis B immunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

A two-dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

To kill or to cure: options in host defense against viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Stimulation of a memory B cell response does not require primed helper T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

A prospective study of in vitro anti-HBs producing B cells (spot-ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Is booster injection with hepatitis B vaccine necessary in healthy responders? A study of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Hepatitis B vaccine boosting: the debate continues

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

On immunological memory

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

The role of B cells in acute and chronic infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: Immunogenicity and anamnestic responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Twelve-year follow-up study of hepatitis B immunization of Senegalese infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Hepatitis B vaccination in children: persistence of immunity at 9 years

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Hepatitis B virus. The major etiology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Long term immune response of universal hepatitis B vaccination in infancy: a community-based study in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Induction of long-lived germinal centers associated with persisting antigen after viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Maintenance of B-cell memory by long-lived cells generated from proliferating precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Humoral immunity due to long-lived plasma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Virus-specific CD8+ T-cell memory determined by clonal burst size

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Cytotoxic T-cell memory without antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

On the role of antigen in maintaining cytotoxic T-cell memory

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Skin test to assess virus-specific cytotoxic T-cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

B-cell memory is short-lived in the absence of antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Regulation of IgG antibody titers by the amount persisting of immune-complexed antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

Neutralizing antiviral B cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

The influence of antigen organization on B cell responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

The influence of virus structure on antibody responses and virus serotype formation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900224-3

7 January 2021

10.1016/S0264-410X(00)00224-3

Identifiers

DOI

1 reference

31 July 2017

1 reference